Products Categories
CAS No.: | 6106-07-6 |
---|---|
Name: | Sodium levothyroxine pentahydrate |
Molecular Structure: | |
|
|
Formula: | C15H11 I4 N O4 . 5 H2 O . Na |
Molecular Weight: | 888.95 |
Synonyms: | Alanine,3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]-, monosodium salt,pentahydrate, L- (8CI); L-Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-,monosodium salt, pentahydrate (9CI); 3',3,5',5-Tetraiodo-L-thyronine sodiumsalt pentahydrate; Sodium levothyroxine pentahydrate |
Density: | 2.381 |
Melting Point: |
207-210 (dec.)(lit.) |
Hazard Symbols: | A reproductive hazard. |
Risk Codes: | 40 |
Safety: | Experimental reproductive effects. When heated to decomposition it emits toxic vapors of NOx and I−. |
PSA: | 141.76000 |
LogP: | 3.60140 |
What can I do for you?
Get Best Price
IUPAC Name: Sodium 2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoate pentahydrate
Synonyms: 3-[4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]-L-alanine sodium salt ; Alanine, 3-(4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)-, monosodium salt, pentahydrate ; L-Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-, sodium salt, pentahydrate ; O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodo-L-tyrosine sodium salt pentahydrate ; Sodium levothyroxine ; Sodium L-thyroxine pentahydrate
Molecular Structure of Sodium l-thyroxine pentahydrate (CAS NO.6106-07-6) :
Molecular Formula of Sodium l-thyroxine pentahydrate (CAS NO.6106-07-6) : C15H10I4NNaO4.5(H2O)
Molecular Weight of Sodium l-thyroxine pentahydrate (CAS NO.6106-07-6) : 888.93
CAS NO: 6106-07-6
Product Categories: Hormones
Mol File: 6106-07-6.mol
Flash Point: 302.3 °C
Enthalpy of Vaporization: 90.78 kJ/mol
Boiling Point: 576.3 °C at 760 mmHg
Vapour Pressure: 4.02E-14 mmHg at 25°C
Melting point: 207-210 (dec.)(lit.)
Storage temp. 2-8°C
Solubility : cell culture medium: 0.1 mg/mL
Form : powder
Experimental reproductive effects. When heated to decomposition it emits toxic vapors of NOx and I−.
Hazard CodesXn
Risk Statements 40
R40:Limited evidence of a carcinogenic effect.
Safety Statements 22-24/25-36
S22:Do not breathe dust.
S24/25:Avoid contact with skin and eyes.
S36:Wear suitable protective clothing.
WGK Germany 3
RTECS YP2833760
F 3-8-10